on GENEURO SA (EPA:GNRO)
Temporary suspension of trading of GeNeuro SA shares on Euronext Paris
On January 23, 2026, GeNeuro SA announced the temporary suspension of trading of its shares on Euronext Paris. This decision follows a request from the company pending a ruling from the Geneva Court of First Instance regarding its composition agreement.
GeNeuro SA, specializing in the development of treatments for neurodegenerative diseases, had obtained a four-month extension for its final composition moratorium in September 2025. The upcoming judgment could influence the restructuring of the company.
The verdict is expected on January 27, 2026, and will be officially announced. This process could lead to a recapitalization or restructuring of GeNeuro SA's debt.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GENEURO SA news